
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Details : Leucine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Drug Resistant Epilepsy.
Product Name : Undisclosed
Product Type : Amino Acid
Upfront Cash : Inapplicable
April 26, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Glytactin
Therapeutic Area : Genetic Disease
Study Phase : Undisclosed
Sponsor : Birmingham Children's Hospital | Great Ormond Street Hospital for Children NHS Foundation Trust
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of Low Phenylalanine Formulas
Details : Glytactin is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Phenylketonurias.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
March 27, 2024
Lead Product(s) : Glytactin
Therapeutic Area : Genetic Disease
Highest Development Status : Undisclosed
Sponsor : Birmingham Children's Hospital | Great Ormond Street Hospital for Children NHS Foundation Trust
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Denileukin Diftitox
Therapeutic Area : Oncology
Study Phase : Phase III
Recipient : Citius Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : LYMPHIR (denileukin diftitox-cxdl) is a recombinant fusion protein that combines the interleukin-2 (IL-2) receptor binding domain with diphtheria toxin fragments.
Product Name : Lymphir
Product Type : Protein
Upfront Cash : Inapplicable
July 29, 2023
Lead Product(s) : Denileukin Diftitox
Therapeutic Area : Oncology
Highest Development Status : Phase III
Recipient : Citius Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : University of Toronto
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Amino Acid on Muscle Damage
Details : This drug candidate is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 24, 2017
Lead Product(s) : Undisclosed
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : University of Toronto
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Amino Acids Mixture
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Sponsor : Daniel Moore
Deal Size : Inapplicable
Deal Type : Inapplicable
Protein Requirements for Active Children
Details : Amino Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Metabolic Diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 22, 2017
Lead Product(s) : Amino Acids Mixture
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Sponsor : Daniel Moore
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Base Egg Protein
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Recipient : University of Toronto
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Non-essential Amino Acids on Protein Requirements for Endurance Athletes
Details : Base Egg Protein is a Protein drug candidate, which is currently being evaluated in clinical studies for the treatment of Metabolic Diseases.
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
August 22, 2016
Lead Product(s) : Base Egg Protein
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Recipient : University of Toronto
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Amino Acids Mixture
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : University of Toronto
Deal Size : Inapplicable
Deal Type : Inapplicable
Protein Requirements for Active Adolescent Males (IAAO-AM)
Details : Amino Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 08, 2016
Lead Product(s) : Amino Acids Mixture
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : University of Toronto
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Amino Acids Mixture
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Recipient : University of Toronto
Deal Size : Inapplicable
Deal Type : Inapplicable
Protein Requirements for Active Adolescent Females
Details : Amino Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Metabolic Diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 15, 2016
Lead Product(s) : Amino Acids Mixture
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Recipient : University of Toronto
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : University of Toronto
Deal Size : Inapplicable
Deal Type : Inapplicable
The Impact of Protein Intake on Protein Metabolism During Intensified Training
Details : This drug candidate is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 15, 2016
Lead Product(s) : Undisclosed
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : University of Toronto
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Amino Acids Mixture
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Recipient : University of Toronto
Deal Size : Inapplicable
Deal Type : Inapplicable
Protein Requirements In Active Female Populations
Details : Amino Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Metabolic Diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 10, 2015
Lead Product(s) : Amino Acids Mixture
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Recipient : University of Toronto
Deal Size : Inapplicable
Deal Type : Inapplicable
